NEW YORK (GenomeWeb) – BC Platforms announced today that it has signed a deal to combine its genomic data management platform with Nexus Personalized Health Technologies' genomic data analysis and integration technologies.
Specific terms of the arrangement were not disclosed.
Nexus, a part of the Swiss Federal Institute of Technology in Zurich, "is committed to integrating genomic data alongside clinical data to become a leader in translational research in order to provide the best clinical outcomes for patients," Daniel Stekhoven, head of clinical bioformatics at Nexus, said in a statement. "We are pleased to be working with BC Platforms … to provide joint solutions to tackle current genomic data challenges and practically link those to clinical benefits."
"We now have the tools and technologies for the interpretation of complex proprietary genomic data in combination with publicly available clinical data through local initiatives in Switzerland and internationally," BC Platforms CEO Tero Silvola added in the statement.